Following standard Hurtley reaction, by using 2-Bromobenzoic acid, resorcinol and NaOH in the presence of CuSO4 solution as a catalyst, a clay coloured solid of dibenzo-α-pyrone was prepared. This resulting solid of DBαP was then reacted with various amines respectively, formaldehyde and ethanol and refluxed for 1.5 h as per Mannich reaction resulting into eleven new synthetic Mannich derivatives of DBαP. The characterisation of synthesised new compounds were done by various spectral (UV, IR and NMR) and analytical methods. The synthesised derivatives were also evaluated for their analgesic activity using different animal models (Tail clip test and Hot plate method). Some of these compounds exhibited promising activities.
INTRODUCTION
From decades, Non-Steroidal anti-inflammatory drugs (NSAIDS) are widely used for the treatment of pain and inflammation as therapeutic agents. They act primarily on peripheral pain mechanisms. They do not produce physical dependence, have no abuse liability and are weaker analgesics. However, their long term clinical usage produces significant side effects such as bleeding, gastrointestinal lesions and nephrotoxicity. Therefore, it's a challenging goal in the research field for the discovery of new and safer synthetic analgesics and antiinflammatory agents. Generally, NSAIDS block PG generation, which is considered the major mechanism of action of NSAIDS. Prostaglandin (PG), prostacyclin (PGI 2 ) and thromboxane (TXA 2 ) are produced from arachidonic acid by the enzyme cyclo-oxygenase which exists in two isoforms constitutive (COX 1) and inducible (COX 2) isoforms. COX 1 serves physiological 'house keeping' functions while the COX 2 serves the generation of PGs and inflammation action. PGs induce hyper analgesia by affecting the transducing property of free nerve endings. NSAIDS block the pain sensitizing mechanism induced by bradykinin, TNFα, interleukins (ILs) and other algesic substances. Therefore, more effective against inflammation associated pain. Literature reports shows that Shilajit is a rejuvenator of Ayurvedic origin and is found in layers of rocks in many mountain ranges especially Himalayas and Hindukush ranges. DBαP is an active constituent of herbal drug Shilajit. Clinical research reported its analgesic, antiinflammatory, anti-oxidant, anti aging, antialzheimer, anti-ulcerogenic, immunomodulator, adaptogenic activities and nutritive tonic.
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MATERIALS AND METHODS Chemistry
The target compounds were synthesised as outlined in scheme 1 and scheme 2. The starting material dibenzo-α-pyrone was prepared using a solution of 2-Bromobenzoic acid, resorcinol and NaOH in (round bottom flask) RBF and was heated under reflux for 30 minutes to 60°C and treated with CuSO 4 solution (10 %). Then, the mixture is heated at 80°-90°C for 10 minutes and it was stirred vigorously until it was thicken. [8] [9] The resulting DBαP was mixed with various amines (2a-k) respectively followed by formaldehyde and ethanol in a RBF and refluxed for 1.5 h as per Mannich reaction.
Experimental
All melting points were in degree centigrade and were determined using open capillary method with Perfit melting point apparatus and were uncorrected. The progress of the reaction and the purity of the product were determined by thin layer chromatography (TLC) using hexane: ethyl acetate as solvent system. IR spectra were recorded as KBr pellets on a Jasco FT/ IR-4100 type.
1 H NMR was recorded on Brucker 400 MHz NMR spectrometer using DMSO as a solvent. UV spectra were recorded on Schimadzu-1800 type.
Pharmacology
Eddy's Hot Plate and Tail clip method was used for determination of analgesic activity. [10] [11] [12] [13] [14] [15] The activity was performed using standard procedures and ethics (Institutional Ethical Clearance number ITS/05/IAEC/2013)
Animals
The healthy Swiss albino mice of both sexes weighing 25-30 g were taken for the study. The animals were kept in hygienic cages with proper space during the course of experimental period. The animals are kept on standard commercial diet and water ad libitum and were kept in rooms maintained at 22°± 1°C with 12 h dark life cycle. 
Analgesic activity using Hot plate test
The experiment was carried out using Vogel's method, using hot plate apparatus, maintained at 55°± 0.5°C. The mice were divided into 14 groups of 6 animals each and used for each dose. The hot plate, which is commercially available, consists of an electrically heated surface. The animals are placed on the hot plate and the time until either licking or jumping occurs is recorded by a stopwatch. The reaction time was measured prior to administration of synthesised compounds and drug administration (0 minute). Group 1 was kept as normal control group. Group 2 was served as standard and were treated with diclofenac 10 mg/kg orally. The synthesised compounds were injected orally to mice of group 3-14 at three different doses 10 mg/kg, 20 mg/kg and 30 mg/kg.
The reaction time was measured after the treatment at 0, 30, 60, 90 minutes. To avoid tissue damage to the mice paws, cut-off time for the response to the thermal stimulus was set at 60 s.
Analgesic activity using Haffner's Tail clip method
The experiment was carried out using Vogel's method, using an artery clip. An artery clip is applied to the root of the tail of mice and the reaction time is noted. Mice with a weight between 18 to 25 g were used. The mice were divided into 14 groups of 6 animals each and used for each dose. The test compounds were administered orally to fasted animals. The reaction time was measured after the treatment at 0, 30, 60, 90 minutes. An artery clip was applied to root of the tail (approximately 1 cm from the body) to induce pain. The animal quickly responds to the noxious stimuli by biting the clip or the tail near the location of the clip. 
RESULTS AND DISCUSSION
